Clinical Trials Logo

Urinary Tract Infections clinical trials

View clinical trials related to Urinary Tract Infections.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06344884 Not yet recruiting - Clinical trials for Urinary Retention Postoperative

Early Patient Removal of Urinary Catheters After Urogynecologic Surgery

CARES2
Start date: May 2024
Phase: N/A
Study type: Interventional

Management of postoperative urinary retention often requires the use of indwelling catheters. In a previous study, the investigators determined that patient removal of catheters at home is non-inferior to standard office removal on postoperative day three or four (POD3-4). The purpose of this study is to determine whether patient removal of catheters at home on postoperative day one (POD1) is noninferior to removal on POD 3-4.

NCT ID: NCT06332781 Not yet recruiting - Recurrent Uti Clinical Trials

Intravesical Gentamicin to Prevent Recurrent UTI

Start date: August 1, 2024
Phase: Phase 4
Study type: Interventional

Feasibility assessment of intravesical gentamicin instillation (putting antibiotics directly into the bladder) versus the current standard of care of oral nitrofurantoin prophylaxis (taking a low dose of antibiotics by mouth every day) to prevent recurrent urinary tract infections (UTI)

NCT ID: NCT06319352 Not yet recruiting - Quality of Life Clinical Trials

Evaluation of Quality-of-Life Improvements Using UroShield Device

Start date: May 31, 2024
Phase: N/A
Study type: Interventional

The goal of this pilot study is to test key elements of the full study that will follow, including recruitment and retention strategies, intervention delivery, laboratory testing, data collection methods, and adherence to study protocol. The main questions the investigators aim to answer focus on implementation and practicality: - Recruitment feasibility and time to recruit - How well do participants adhere to device protocol? - How often do device components (i.e., actuators and drivers) have to be replaced? - How much time is required for data collection and what sources or methods for data collection are used? Results of this pilot study will inform the investigators as to necessary protocol modifications and overall feasibility for the larger randomized clinical trial to follow.

NCT ID: NCT06307067 Not yet recruiting - Clinical trials for Urinary Tract Infections

Improving Care for Uncomplicated URinary Tract Infection-associated Symptoms in Primary Healthcare Settings in INDOnesia

URINDO
Start date: March 4, 2024
Phase:
Study type: Observational [Patient Registry]

In the present study, we aim to analyze the impact of the introduction of a urinary dipstick test for patients presenting with uncomplicated UTI-associated symptoms on antibiotic prescription in primary health care in Indonesia. In addition, the knowledge of HCW regarding antibiotics and prudent use of antibiotics in the community setting will be investigated. Specific aims of the study: 1. To analyze the quality of antibiotic prescriptions for uncomplicated UTI in the primary health care settings in Indonesia, before introduction of urinary dipstick testing compared to after introduction of urinary dipstick testing. 2. To analyze the knowledge level of healthcare workers on uncomplicated UTI and prudent antibiotic use in primary health care settings in Indonesia.

NCT ID: NCT06297837 Not yet recruiting - Clinical trials for Urinary Tract Infections

ADAPT-AST (Adaptive Antimicrobial Susceptibility Testing)

ADAPT-AST
Start date: March 2024
Phase:
Study type: Observational

The goal of this study is to improve the way urinary tract infections (UTIs) are tested for antibiotic resistance. The main questions it aims to answer are: - Can the investigators use a method called Bayesian causal inference to create or check clinical prediction models that help predict if certain antibiotics will work for a urinary infection, using patient information from the National Health Service (NHS)? - Can this new ADAPT-AST method, which uses data and a smarter approach, do a better job of testing for urinary infection than the old methods? Will it help doctors make quicker decisions and save resources by being more efficient? Participants in this study will not be receiving treatments. The study will involve: Using statistical methods to predict UTI test results based on patient data. Evaluating whether this new approach can provide doctors with more timely and useful information for treating UTIs. Assessing whether it can help save money and resources in the lab and pharmacy.

NCT ID: NCT06296901 Not yet recruiting - Clinical trials for Urinary Tract Infections

To Wipe or Not To Wipe?: That Is The Question

Start date: April 2024
Phase: N/A
Study type: Interventional

The primary aim of this randomized control trial is to characterize whether a mid-stream clean catch sample using a cleansing wipe in the setting of symptomatic UTI in a female patient is associated with a lower rate of contamination. We hypothesize that using a perineal cleansing wipe at the time of a midstream urine sample will decrease rates of contamination for female patients with a symptomatic UTI.

NCT ID: NCT06265142 Not yet recruiting - Clinical trials for Urinary Tract Infections

Clean Catch Urine Feasibility and Contamination Rate Compared to Bladder Catheterization Urine in Pre-Continent Children

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

Introduction: Urinary tract infections (UTIs) are a common source of infection in children, accounting for a significant proportion of visits every year. Diagnosing UTIs requires obtaining a urine specimen, which can be collected using four methods: invasive techniques, such as suprapubic aspiration and urethral bladder catheterization, and noninvasive techniques, such as sterile bag and clean catch. However, catheterization can be a painful and invasive procedure, particularly in young infants who are less cooperative, and sometimes tends to be rejected by parents. Given the availability of alternative methods with comparable contamination rates, we aim to investigate the feasibility and contamination rate of clean catch urine compared to bladder catheterization, as well as secondary outcomes such as pain scores, parental satisfaction, and time required to collect urine for each technique. Methods: To achieve this, we will conduct a randomized control trial in precontinent pediatric patients. A pilot study with 40 samples in each arm will be conducted since there is no prior information about contamination rates in our setting. A well-designed and labeled data collection sheets will be used for data collection, and the data will be entered using EPI-data software. Statistical analysis will be performed using IBM SPSS statistics. Aim: The main aim of this study is to introduce clean catch urine (bladder massage technique) to our setting, and to compare its feasibility with the bladder catheterization which is the standard practice. Patient Population: young infants from 0 to 6 months of age Intervention: There will be two groups: 1. Group A (Experimental group):Urine samples will be collected using the clean catch urine method (bladder massage technique). 2. Group B (Control group): Urine samples will be collected using the standard bladder catheterization method. Clinical Measurement: All collected urine samples will be labeled and sent to the laboratory. All results will be retrieved from the medical records. Direct measurement will be for the duration of the procedures in both experiment and control group (stopwatch will be used). Pain score (Neonatal Infant Pain Scale) and parental satisfaction survey will be filled at the time of the procedure. Outcome: Contamination rate and feasibility of both urine sampling techniques

NCT ID: NCT06251336 Not yet recruiting - Clinical trials for Urinary Tract Infections

Uroial Plus in the Management of Infections and Urinary Symptoms Associated With Ureteral Stents

USSIAL
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Double-blind randomised interventional pilot study. To evaluate whether therapy with UroialTM Plus has a role in rebalancing homeostasis in ureteral stent patients, improving symptoms related to the presence of the ureteral stent in place. Ureteral stent patients will be randomised into two groups: - the experimental group will receive UroialTM Plus sachets, one sachet daily at bedtime after urinating, for 30 days - the control group will receive a placebo, one sachet daily in the evening before going to bed after urinating, for 30 days. At each visit, the investigator will assess the possible occurrence of urinary symptoms, their severity and their impact on quality of life by administering the following questionnaires: IPSS, USSQ, AIA, SF-36, VAS, EQ-5D-5L.

NCT ID: NCT06230042 Not yet recruiting - Urinary Catheter Clinical Trials

Catheter in the Prevention of Urinary Tract Infections and Crystallization Study(CPUTICS)

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

This is a single-center randomized controlled trial in comparison of Parylene-Coated versus Silicone Catheters in the Prevention of Urinary Tract Infections and Crystallization.

NCT ID: NCT06149455 Not yet recruiting - Nephrolithiasis Clinical Trials

Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy

Start date: January 1, 2024
Phase: N/A
Study type: Interventional

The goal of this non-inferiority randomized controlled trial: is to test the hypothesis that the that there is no additional benefit from a longer course (7 days) versus a shorter course (2 days) of pre-operative antibiotics in patients with moderate to high risk of infection undergoing ureteroscopy. The main questions it aims to answer are: 1. Determine the safety and efficacy of a short course (2 days) as compared to a long course (7 days) 2. Identify secondary predictors of post-operative infectious complications